Monochemotherapy vs. doublet vs. triplet chemotherapy (CTX) with predefined sequence for 2nd-line therapy in stage IIIb and IV NSCLC: A randomised phase III trial

19008 Background: The optimal intensity of CTX for palliative treatment in stage IIIb/IV NSCLC is still unclear. We initiated a prospective, randomised phase III trial comparing mono vs. doublet vs...